| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/29/2008 | US20080125574 Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses |
| 05/29/2008 | US20080125498 Treatment of neurodegenerative diseases and conditions using par1 antagonists |
| 05/29/2008 | US20080125487 fatty acid synthase genes involved in the elongation of long-chain polyunsaturated fatty acids, used in the conversion of fatty acids such as gamma-linolenic acid to dihomo-gamma-linolenic acid or stearidonic acid to eicosatetraenoic acid; additives for drugs, cosmetics or feeds |
| 05/29/2008 | US20080125465 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 05/29/2008 | US20080125446 For example, 6-amino-2-(chloro or fluoro)-8-(arylthio(oxo))-9H-purines; complex with Heat Shock Protein 90 (HSP 90); proliferative disorders such as breast cancer |
| 05/29/2008 | US20080125388 treating or preventing a condition of excessive cell death by administering a nucleic acid molecule encoding a protein having CPG15-2 biological activity; acts as survival factor by rescuing hippocampal and cortical neurons from cell death; inhibiting activity of CPG15-2 for cancer treatment |
| 05/29/2008 | US20080125387 Administering vector system that directs regulated erythropoietin (Epo) gene therapy in a manner that physiologically corrects the hematocrit levels in a patient in need of anemia treatment |
| 05/29/2008 | US20080125374 Gd3-mimetic peptides |
| 05/29/2008 | US20080125373 Motoneuronotrophic factors (MNTF); nerve growth factors; spinal cord injuries; neurodegenerative diseases |
| 05/29/2008 | US20080125372 Biologically Active Peptide Vapeehptllteaplnpk Derivatives |
| 05/29/2008 | US20080125371 Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP) |
| 05/29/2008 | US20080125369 Soluble t cell receptors |
| 05/29/2008 | US20080125367 Agents for treatment of HCV and methods of use |
| 05/29/2008 | US20080125366 Insecticidal proteins derived from Bacillus Thuringiensis |
| 05/29/2008 | US20080125365 Fibronectins; inflammation |
| 05/29/2008 | US20080125363 Nonantigenic; biochemical conjugation; polyoxyethylene glycol; anticancer agents |
| 05/29/2008 | US20080125362 Method of screening compound preventing cells from infection with Hepatitis C virus (HCV) |
| 05/29/2008 | US20080125361 Stable Formulations Of Peptides |
| 05/29/2008 | US20080125359 Antimicrobial peptides and methods of identifying the same |
| 05/29/2008 | US20080125357 Novel peptide ligand to the orphan G-protein coupled receptor ChemerinR; Prochemerin and Chemerin amino acid sequences; use in diagnosis and immunotherapy of a disease including tumors |
| 05/29/2008 | US20080125355 Endogenous Peptide and Active Subfragments Thereof |
| 05/29/2008 | US20080125352 Unique Integrin Binding Site in Connective Tissue Growth Factor |
| 05/29/2008 | US20080125351 Forming water-in-oil emulsion from aqueous phase (water soluble polypeptide and sugar) and oil phase comprising glycolic acid-lactic acid copolymer and solvent, adding silicone oil, hardening, drying; optimizing the silicone oil to polymer ratio to improve bioavailability of peptide drug |
| 05/29/2008 | US20080125332 Methods, Kits and Compositions Pertaining to Combination Oligomers and Libraries for Their Preparation |
| 05/29/2008 | US20080124803 cDNA Corresponding to the antigenome of nonsegmented negative stranded RNA viruses and process for the production of such viruses |
| 05/29/2008 | US20080124800 Preparing competent embryonic plant tissues to undergo somatic embryogenesis; lant regeneration and transformation; tissue engineering |
| 05/29/2008 | US20080124799 Plant activation of insect toxin |
| 05/29/2008 | US20080124798 Using plant cell as bioreactor for production of glycosyltransferase |
| 05/29/2008 | US20080124794 Expression vector comprising nucleotide sequences coding streptococcal surface protein for use in detection, prevention and treatment of microorganismal infection |
| 05/29/2008 | US20080124793 Membrane fusion proteins derived from reoviridae for use in delivery of bioactive drugs to cells |
| 05/29/2008 | US20080124786 Expression vector comprising nucleotide sequences coding diacylglycerol acyltransferases for use in enhancing omega fatty acids production in yarrowia |
| 05/29/2008 | US20080124782 Using lysyl hydroxylase enzyme having glycosyltransferase activity to glycosylate hydroxylysine residues in polypeptides |
| 05/29/2008 | US20080124763 Constructs and methods for expression of recombinant proteins in methylotrophic yeast cells |
| 05/29/2008 | US20080124759 Novel fgf homolog zfgf12 |
| 05/29/2008 | US20080124757 Used in antibacterial, immunosuppressant, and antitumor drug making; loading an extender molecule on an acyl carrier protein (ACP) domain |
| 05/29/2008 | US20080124741 Canine Cholecystokinin 1 Receptor Materials And Their Use |
| 05/29/2008 | US20080124739 Compositions and methods for the diagnosis and treatment of tumor |
| 05/29/2008 | US20080124729 Using presence of mutant microsatellite in particular chromosomal regions as diagnostic indicator for cell proliferative disorders |
| 05/29/2008 | US20080124728 Removal of Molecular Assay Interferences for Nucleic Acids Employing Buffered Solutions of Chaotropes |
| 05/29/2008 | US20080124702 Methods of diagnosing cervical cancer |
| 05/29/2008 | US20080124380 Contacting male ejaculate, prior to contact with a female egg, with an effective anti-fertility amount of a pharmaceutical composition, which comprises an antibody that binds a surface exposed epitope of SP22, and a pharmaceutically acceptable carrier |
| 05/29/2008 | US20080124362 Domain II Mutants Of Anthrax Lethal Factor |
| 05/29/2008 | US20080124360 Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes |
| 05/29/2008 | US20080124358 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 05/29/2008 | US20080124353 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/29/2008 | US20080124351 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/29/2008 | US20080124347 Insulinotropic peptide conjugate using carrier substance |
| 05/29/2008 | US20080124337 Immunoglobulin for use in diagnosis, prevention and treatment of neisserial infection; immunootherapeutics |
| 05/29/2008 | US20080124336 Molecules and Methods for Inhibiting Shedding of KIM-1 |
| 05/29/2008 | US20080124335 Novel Polypeptide and the Use Thereof |
| 05/29/2008 | US20080124322 Activation and inhibition of the immune system |
| 05/29/2008 | US20080124320 High mobility group box (HMGB) protein which inhibits proinflammatory cytokine cascade for use in prevention and/or treatment of weight loss/obesity disorders |
| 05/29/2008 | US20080124317 Diagnos and Treatment of Fibrosis Related Pathology |
| 05/29/2008 | US20080124309 Cell Surface Glycoprotein |
| 05/29/2008 | US20080124308 Gene Therapy of Solid Tumours by Means of Retroviral Vectors Pseudotyped With Arenavirus Glycoproteins |
| 05/29/2008 | US20080124302 Modified cytokine for use in treatment and prevention of viral and cell proliferative disorders |
| 05/29/2008 | US20080124299 prophylaxis of liver disorders caused by hepatitis virus by administering interleukins or conjugated interleukins to mammals; viricides |
| 05/29/2008 | US20080124284 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with Porphyromonas gingivalis |
| 05/29/2008 | US20080124277 Human and Mouse Targeting Peptides Identified by Phage Display |
| 05/29/2008 | CA2670446A1 Ilt-2 (liri) variants with increased affinity for mhc class i molecules |
| 05/29/2008 | CA2670389A1 Transgenic animal with enhanced immune response and method for the preparation thereof |
| 05/29/2008 | CA2670318A1 Polypeptide monomers and dimers containing mutated ilt |
| 05/29/2008 | CA2669975A1 Ph.alpha.1b toxin, cdna of ph.alpha.1b toxin gene, pharmaceutical compositions containing ph.alpha.1b toxin, processes for their obtention and product |
| 05/29/2008 | CA2669933A1 Method of use of epiregulin protein and nucleic acid encoding the same in inflammatory conditions |
| 05/29/2008 | CA2669558A1 Compositions and methods related to toll-like receptor-3 |
| 05/29/2008 | CA2669275A1 Agent for inhibiting cytokinin signaling |
| 05/29/2008 | CA2665644A1 Antibodies to lymphotoxin-alpha |
| 05/29/2008 | CA2665033A1 Antidiabetic compounds |
| 05/28/2008 | EP1925937A1 Method for assaying antigen related to disorders caused by mental stress |
| 05/28/2008 | EP1925672A1 Abiotic stress responsive polynucleotides and polypeptides |
| 05/28/2008 | EP1925671A1 Flax (Linum usitatissimum L.) seed-specific promoters |
| 05/28/2008 | EP1925668A2 Genes involved in the biosynthesis of thiocoraline and heterologous production of same |
| 05/28/2008 | EP1925667A1 Specific protein of the pancreatic beta cells of the Langerhans' islands and its applications |
| 05/28/2008 | EP1925666A1 Human Toll-like receptor proteins, related reagents and methods |
| 05/28/2008 | EP1925664A1 Artificial binding proteins based on a modified alpha helical region of ubiquitin |
| 05/28/2008 | EP1925662A1 Recombinant Poxvirus-Cytomegalovirus Compositions and uses |
| 05/28/2008 | EP1925626A1 Novel multifunctional cytokines |
| 05/28/2008 | EP1925625A2 Method for screening modulators of mitochondrial functionning and new modulators obtained |
| 05/28/2008 | EP1925320A2 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
| 05/28/2008 | EP1924857A2 Vdcc gamma-8 ion channel |
| 05/28/2008 | EP1924696A2 Methods for genetic control of insect infestations in plants and compositions thereof |
| 05/28/2008 | EP1924694A1 Method for producing amino acids using micro-organisms |
| 05/28/2008 | EP1924691A1 Gene silencing of protease activated receptor 1 (par1) |
| 05/28/2008 | EP1924689A1 Hydrophobic interaction chromatography purification of factor vii polypeptides |
| 05/28/2008 | EP1924688A1 Purification of coagulation factor vii polypeptides |
| 05/28/2008 | EP1924603A2 Prok2 antagonists and methods of use |
| 05/28/2008 | EP1924601A1 Expression of proteins in e.coli |
| 05/28/2008 | EP1924600A2 Identification of tumor-associated antigens for diagnosis and therapy |
| 05/28/2008 | EP1924599A2 Acaricidal compositions and methods of use thereof |
| 05/28/2008 | EP1924598A2 Esterase gene and use thereof |
| 05/28/2008 | EP1924597A2 Vaccines comprising truncated hbc core protein plus saponin-based adjuvants |
| 05/28/2008 | EP1924596A2 Albumin fusion proteins |
| 05/28/2008 | EP1924282A2 Immunization of avians by administration of non-replicating vectored vaccines |
| 05/28/2008 | EP1924281A2 Modified influenza virus for monitoring and improving vaccine efficiency |
| 05/28/2008 | EP1924136A2 Dominant negative mutant krp protein protection of active cyclin-cdk complex inhibition by wild-type krp |
| 05/28/2008 | EP1786917A4 Optimized interferon-beta gene |
| 05/28/2008 | EP1765058A4 Nucleic acid molecules and their use in plant male sterility |
| 05/28/2008 | EP1765056A4 Markers for salinity tolerance in wheat plants and the use thereof in breeding programs |
| 05/28/2008 | EP1747228A4 Novel compositions and methods in cancer |
| 05/28/2008 | EP1641820B1 Rasgap derived peptide for selectively killing cancer cells |